Source link : https://newshealth.biz/health-news/novel-agent-safe-in-als-phase-ii-study-suggests/
(MedPage Today) — Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily dose of the drug outperformed placebo for the primary outcome in a phase II trial in China. At 180 days… Source link : https://www.medpagetoday.com/neurology/generalneurology/114420 Author : Publish date : 2025-02-27 21:55:46 Copyright for syndicated […]
Author : News Health
Publish date : 2025-02-27 21:55:46
Copyright for syndicated content belongs to the linked Source.